News in brief: Mobilising regimen quirk in myeloma patients; GP in trouble for LMWH slip; Hairy cell leukaemia guidance for COVID-19

Post-transplant mobilising regimen impact survival in myeloma patients Patients with multiple myeloma have better overall survival (OS) after autologous transplant with a G-CSF only mobilising regimen compared with G-CSF and cyclophosphamide, an Australian study shows. The findings comes from a retrospective review of outcomes for 601 patients treated at 12 transplant centres with bortezomib, cyclophosphamide ...

Already a member?

Login to keep reading.

© 2021 the limbic